Takaisin Tulosta

Kaksisuuntainen mielialahäiriö ja raskaus

Lisätietoa aiheesta
Heli Malm, LT, dosentti, naistentautien ja synnytysten erikoislääkäri, Teratologinen tietopalvelu, Helsingin yliopisto ja HUS Akuutti etäpalvelut ja Hanna Valtonen






Foolihappolisän merkitys


  1. Poels EMP, Bijma HH, Galbally M ym. Lithium during pregnancy and after delivery: a review. Int J Bipolar Disord 2018;6:26 «PMID: 30506447»PubMed
  2. Viguera AC, Newport DJ, Ritchie J ym. Lithium in breast milk and nursing infants: clinical implications. Am J Psychiatry 2007;164:342-5 «PMID: 17267800»PubMed
  3. European Medicines Agency. PRAC recommends new measures to avoid valproate exposure in pregnancy. https://www.ema.europa.eu/en/news/prac-recommends-new-measures-avoid-valproate-exposure-pregnancy (9.2.2018)
  4. Tomson T, Landmark CJ, Battino D. Antiepileptic drug treatment in pregnancy: changes in drug disposition and their clinical implications. Epilepsia 2013;54:405-14 «PMID: 23360413»PubMed
  5. Malm H. Kaksisuuntaisen mielialahäiriön lääkehoito ja raskaus. Suom Lääkäril 2018;23:1508-10
  6. Patorno E, Huybrechts KF, Bateman BT ym. Lithium Use in Pregnancy and the Risk of Cardiac Malformations. N Engl J Med 2017;376:2245-2254 «PMID: 28591541»PubMed
  7. Boyle B, Garne E, Loane M ym. The changing epidemiology of Ebstein's anomaly and its relationship with maternal mental health conditions: a European registry-based study. Cardiol Young 2017;27:677-685 «PMID: 27572669»PubMed
  8. Diav-Citrin O, Shechtman S, Tahover E ym. Pregnancy outcome following in utero exposure to lithium: a prospective, comparative, observational study. Am J Psychiatry 2014;171:785-94 «PMID: 24781368»PubMed
  9. Munk-Olsen T, Liu X, Viktorin A ym. Maternal and infant outcomes associated with lithium use in pregnancy: an international collaborative meta-analysis of six cohort studies. Lancet Psychiatry 2018;5:644-652 «PMID: 29929874»PubMed
  10. Wesseloo R, Wierdsma AI, van Kamp IL ym. Lithium dosing strategies during pregnancy and the postpartum period. Br J Psychiatry 2017;211:31-36 «PMID: 28673946»PubMed
  11. Westin AA, Brekke M, Molden E ym. Changes in drug disposition of lithium during pregnancy: a retrospective observational study of patient data from two routine therapeutic drug monitoring services in Norway. BMJ Open 2017;7:e015738 «PMID: 28249852»PubMed
  12. van Velzen CL, Clur SA, Rijlaarsdam ME ym. Prenatal diagnosis of congenital heart defects: accuracy and discrepancies in a multicenter cohort. Ultrasound Obstet Gynecol 2016;47:616-22 «PMID: 26350159»PubMed
  13. Veroniki AA, Cogo E, Rios P ym. Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes. BMC Med 2017;15:95 «PMID: 28472982»PubMed
  14. Tomson T, Battino D, Bonizzoni E ym. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Lancet Neurol 2018;17:530-538 «PMID: 29680205»PubMed
  15. Weston J, Bromley R, Jackson CF ym. Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child. Cochrane Database Syst Rev 2016;11:CD010224 «PMID: 27819746»PubMed
  16. Tomson T, Battino D, Bonizzoni E ym. Dose-dependent teratogenicity of valproate in mono- and polytherapy: an observational study. Neurology 2015;85:866-72 «PMID: 26085607»PubMed
  17. Clayton-Smith J, Bromley R, Dean J ym. Diagnosis and management of individuals with Fetal Valproate Spectrum Disorder; a consensus statement from the European Reference Network for Congenital Malformations and Intellectual Disability. Orphanet J Rare Dis 2019;14:180 «PMID: 31324220»PubMed
  18. Bromley RL, Baker GA. Fetal antiepileptic drug exposure and cognitive outcomes. Seizure 2017;44:225-231 «PMID: 27784632»PubMed
  19. Bromley R, Weston J, Adab N ym. Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child. Cochrane Database Syst Rev 2014;:CD010236 «PMID: 25354543»PubMed
  20. Bromley R. The treatment of epilepsy in pregnancy: The neurodevelopmental risks associated with exposure to antiepileptic drugs. Reprod Toxicol 2016;64:203-10 «PMID: 27312074»PubMed
  21. Cohen MJ, Meador KJ, May R ym. Fetal antiepileptic drug exposure and learning and memory functioning at 6?years of age: The NEAD prospective observational study. Epilepsy Behav 2019;92:154-164 «PMID: 30660966»PubMed
  22. Veroniki AA, Rios P, Cogo E ym. Comparative safety of antiepileptic drugs for neurological development in children exposed during pregnancy and breast feeding: a systematic review and network meta-analysis. BMJ Open 2017;7:e017248 «PMID: 28729328»PubMed
  23. Panchaud A, Cohen JM, Patorno E ym. Anticonvulsants and the risk of perinatal bleeding complications: A pregnancy cohort study. Neurology 2018;91:e533-e542 «PMID: 29980637»PubMed
  24. Pariente G, Leibson T, Shulman T ym. Erratum to: Pregnancy Outcomes Following In Utero Exposure to Lamotrigine: A Systematic Review and Meta-Analysis. CNS Drugs 2017;31:451 «PMID: 28512694»PubMed
  25. Dolk H, Wang H, Loane M ym. Lamotrigine use in pregnancy and risk of orofacial cleft and other congenital anomalies. Neurology 2016;86:1716-25 «PMID: 27053714»PubMed
  26. Huybrechts KF, Hernández-Díaz S, Patorno E ym. Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations. JAMA Psychiatry 2016;73:938-46 «PMID: 27540849»PubMed
  27. Damkier P, Videbech P. The Safety of Second-Generation Antipsychotics During Pregnancy: A Clinically Focused Review. CNS Drugs 2018;32:351-366 «PMID: 29637530»PubMed
  28. Ennis ZN, Damkier P. Pregnancy exposure to olanzapine, quetiapine, risperidone, aripiprazole and risk of congenital malformations. A systematic review. Basic Clin Pharmacol Toxicol 2015;116:315-20 «PMID: 25536446»PubMed
  29. Tosato S, Albert U, Tomassi S ym. A Systematized Review of Atypical Antipsychotics in Pregnant Women: Balancing Between Risks of Untreated Illness and Risks of Drug-Related Adverse Effects. J Clin Psychiatry 2017;78:e477-e489 «PMID: 28297592»PubMed
  30. Cohen LS, Góez-Mogollón L, Sosinsky AZ ym. Risk of Major Malformations in Infants Following First-Trimester Exposure to Quetiapine. Am J Psychiatry 2018;175:1225-1231 «PMID: 30111186»PubMed
  31. Cuomo A, Goracci A, Fagiolini A. Aripiprazole use during pregnancy, peripartum and lactation. A systematic literature search and review to inform clinical practice. J Affect Disord 2018;228:229-237 «PMID: 29275156»PubMed
  32. Coughlin CG, Blackwell KA, Bartley C ym. Obstetric and neonatal outcomes after antipsychotic medication exposure in pregnancy. Obstet Gynecol 2015;125:1224-35 «PMID: 25932852»PubMed
  33. Terrana N, Koren G, Pivovarov J ym. Pregnancy Outcomes Following In Utero Exposure to Second-Generation Antipsychotics: A Systematic Review and Meta-Analysis. J Clin Psychopharmacol 2015;35:559-65 «PMID: 26274044»PubMed
  34. Cohen LS, Viguera AC, McInerney KA ym. Reproductive Safety of Second-Generation Antipsychotics: Current Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics. Am J Psychiatry 2016;173:263-70 «PMID: 26441156»PubMed
  35. Uguz F. Antipsychotic Use During Pregnancy and the Risk of Gestational Diabetes Mellitus: A Systematic Review. J Clin Psychopharmacol 2019;39:162-167 «PMID: 30624301»PubMed
  36. Park Y, Hernandez-Diaz S, Bateman BT ym. Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes. Am J Psychiatry 2018;175:564-574 «PMID: 29730938»PubMed
  37. Haskey C, Galbally M. Mood stabilizers in pregnancy and child developmental outcomes: A systematic review. Aust N Z J Psychiatry 2017;51:1087-1097 «PMID: 28825316»PubMed
  38. http://www.thl.fi «http://www.thl.fi»1
  39. Emes RD, Clifford H, Haworth KE ym. Antiepileptic drugs and the fetal epigenome. Epilepsia 2013;54:e16-9 «PMID: 23016625»PubMed
  40. Stephen LJ, Harden C, Tomson T ym. Management of epilepsy in women. Lancet Neurol 2019;18:481-491 «PMID: 30857949»PubMed
  41. Gerard EE, Meador KJ. Managing Epilepsy in Women. Continuum (Minneap Minn) 2016;22:204-26 «PMID: 26844738»PubMed
  42. Patel N, Viguera AC, Baldessarini RJ. Mood-Stabilizing Anticonvulsants, Spina Bifida, and Folate Supplementation: Commentary. J Clin Psychopharmacol 2018;38:7-10 «PMID: 29215383»PubMed
  43. ACOG Committee Opinion No. 762: Prepregnancy Counseling. Obstet Gynecol 2019;133:e78-e89 «PMID: 30575679»PubMed
  44. Mousa A, Naqash A, Lim S. Macronutrient and Micronutrient Intake during Pregnancy: An Overview of Recent Evidence. Nutrients 2019;11: «PMID: 30791647»PubMed
  45. Ban L, Fleming KM, Doyle P ym. Congenital Anomalies in Children of Mothers Taking Antiepileptic Drugs with and without Periconceptional High Dose Folic Acid Use: A Population-Based Cohort Study. PLoS One 2015;10:e0131130 «PMID: 26147467»PubMed
  46. Jentink J, Bakker MK, Nijenhuis CM ym. Does folic acid use decrease the risk for spina bifida after in utero exposure to valproic acid? Pharmacoepidemiol Drug Saf 2010;19:803-7 «PMID: 20680999»PubMed
  47. Tomson T, Battino D, Bonizzoni E ym. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 2011;10:609-17 «PMID: 21652013»PubMed
  48. Morrow JI, Hunt SJ, Russell AJ ym. Folic acid use and major congenital malformations in offspring of women with epilepsy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2009;80:506-11 «PMID: 18977812»PubMed
  49. Husebye ESN, Gilhus NE, Riedel B ym. Verbal abilities in children of mothers with epilepsy: Association to maternal folate status. Neurology 2018;91:e811-e821 «PMID: 30068633»PubMed
  50. Bjørk M, Riedel B, Spigset O ym. Association of Folic Acid Supplementation During Pregnancy With the Risk of Autistic Traits in Children Exposed to Antiepileptic Drugs In Utero. JAMA Neurol 2018;75:160-168 «PMID: 29279889»PubMed
  51. Huhta JC, Linask K. When should we prescribe high-dose folic acid to prevent congenital heart defects? Curr Opin Cardiol 2015;30:125-31 «PMID: 25389654»PubMed
  52. Gentile S. Prophylactic treatment of bipolar disorder in pregnancy and breastfeeding: focus on emerging mood stabilizers. Bipolar Disord 2006;8:207-20 «PMID: 16696822»PubMed
  53. Yonkers KA, Wisner KL, Stowe Z ym. Management of bipolar disorder during pregnancy and the postpartum period. Am J Psychiatry 2004;161:608-20 «PMID: 15056503»PubMed
  54. Malm H. Psyykenlääkkeiden käyttö ja turvallisuus raskauden ja imetyksen aikana. Suom Lääkäril 2005;60:1149-54
  55. Newport DJ, Viguera AC, Beach AJ ym. Lithium placental passage and obstetrical outcome: implications for clinical management during late pregnancy. Am J Psychiatry 2005;162:2162-70 «PMID: 16263858»PubMed
  56. Frassetto F, Tourneur Martel F, Barjhoux CE ym. Goiter in a newborn exposed to lithium in utero. Ann Pharmacother 2002;36:1745-8 «PMID: 12398572»PubMed
  57. Meador KJ, Baker GA, Browning N ym. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol 2013;12:244-52 «PMID: 23352199»PubMed
  58. Lääketietokeskus Oy, Pharmaca Fennica http://www.terveysportti.fi/terveysportti/laakkeet.koti
  59. Kaaja E, Kaaja R, Matila R ym. Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate. Neurology 2002;58:549-53 «PMID: 11865131»PubMed
  60. Hernández-Díaz S, Smith CR, Shen A ym. Comparative safety of antiepileptic drugs during pregnancy. Neurology 2012;78:1692-9 «PMID: 22551726»PubMed
  61. The Lamotrigine Pregnancy Registry. Final Report 1 September 1992 through 31 March 2010. http://pregnancyregistry.gsk.com/documents/lam_spring_2010_final_report.pdf
  62. Ohman I, Beck O, Vitols S ym. Plasma concentrations of lamotrigine and its 2-N-glucuronide metabolite during pregnancy in women with epilepsy. Epilepsia 2008;49:1075-80 «PMID: 18076642»PubMed
  63. Ohman I, Luef G, Tomson T. Effects of pregnancy and contraception on lamotrigine disposition: new insights through analysis of lamotrigine metabolites. Seizure 2008;17:199-202 «PMID: 18201913»PubMed
  64. Einarson A, Boskovic R. Use and safety of antipsychotic drugs during pregnancy. J Psychiatr Pract 2009;15:183-92 «PMID: 19461391»PubMed
  65. Bodén R, Lundgren M, Brandt L ym. Antipsychotics during pregnancy: relation to fetal and maternal metabolic effects. Arch Gen Psychiatry 2012;69:715-21 «PMID: 22752236»PubMed